Cite
HARVARD Citation
Berlin, S. et al. (2020). Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study. IJC heart & vasculature. p. . [Online].